We are live on
!
Find out more
Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
+3.29%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.24%
AUM
$14.5B
AUM Growth
–
Cap. Flow
+$14.5B
Cap. Flow
% of AUM
99.61%
Top 10 Holdings %
Top 10 Hldgs %
15.75%
Holding
358
New
357
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$390M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$312M |
| 3 |
CELG
Celgene Corp
CELG
|
+$280M |
| 4 |
ANDV
Andeavor
ANDV
|
+$255M |
| 5 |
Visa
V
|
+$188M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.77% |
| 2 | Healthcare | 14.81% |
| 3 | Technology | 12.88% |
| 4 | Industrials | 12.71% |
| 5 | Financials | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Northern Trust
NTRS
$33.5B
| $700K | ﹤0.01% |
+12,096
| New | +$676K |
|
302
Astronics
ATRO
$3.74B
| $689K | ﹤0.01% |
+46,091
| New | +$554K |
|
|
FRX
303
DELISTED
FOREST LABORATORIES INC
FRX
| $681K | ﹤0.01% |
+16,600
| New | +$641K |
|
|
PLL
304
DELISTED
PALL CORP
PLL
| $638K | ﹤0.01% |
+9,600
| New | +$649K |
|
305
McCormick & Company Non-Voting
MKC
$14B
| $587K | ﹤0.01% |
+16,680
| New | +$600K |
|
|
MJN
306
DELISTED
Mead Johnson Nutrition Company
MJN
| $581K | ﹤0.01% |
+7,330
| New | +$588K |
|
|
VVTV
307
DELISTED
VALUEVISION MEDIA INC
VVTV
| $574K | ﹤0.01% |
+112,400
| New | +$491K |
|
308
Procter & Gamble
PG
$343B
| $548K | ﹤0.01% |
+7,117
| New | +$559K |
|
309
AB InBev
BUD
$166B
| $546K | ﹤0.01% |
+6,050
| New | +$576K |
|
310
Ingredion
INGR
$6.45B
| $537K | ﹤0.01% |
+8,180
| New | +$575K |
|
311
Colgate-Palmolive
CL
$73B
| $510K | ﹤0.01% |
+8,910
| New | +$529K |
|
|
RSE
312
DELISTED
ROUSE PPTYS INC COM (DE)
RSE
| $491K | ﹤0.01% |
+25,000
| New | +$487K |
|
313
Accuray
ARAY
$35.8M
| $432K | ﹤0.01% |
+75,200
| New | +$380K |
|
314
Union Pacific
UNP
$175B
| $432K | ﹤0.01% |
+5,600
| New | +$422K |
|
315
AGNC Investment
AGNC
$12.7B
| $426K | ﹤0.01% |
+18,530
| New | +$536K |
|
|
CB
316
DELISTED
CHUBB CORPORATION
CB
| $405K | ﹤0.01% |
+4,779
| New | +$418K |
|
|
JBTM
317
JBT Marel
JBTM
$6.91B
| $395K | ﹤0.01% |
+18,800
| New | +$394K |
|
|
IPHI
318
DELISTED
INPHI CORPORATION
IPHI
| $392K | ﹤0.01% |
+35,600
| New | +$360K |
|
|
CSII
319
DELISTED
Cardiovascular Systems, Inc.
CSII
| $388K | ﹤0.01% |
+18,300
| New | +$355K |
|
|
EGL
320
DELISTED
Engility Holdings, Inc.
EGL
| $378K | ﹤0.01% |
+13,300
| New | +$329K |
|
|
CBM
321
DELISTED
Cambrex Corporation
CBM
| $376K | ﹤0.01% |
+26,900
| New | +$352K |
|
|
SNAK
322
DELISTED
Inventure Foods, Inc.
SNAK
| $375K | ﹤0.01% |
+44,800
| New | +$340K |
|
|
KG
323
Kestrel Group
KG
$75.2M
| $370K | ﹤0.01% |
+1,650
| New | +$350K |
|
324
Medtronic
MDT
$110B
| $362K | ﹤0.01% |
+7,034
| New | +$348K |
|
325
Douglas Dynamics
PLOW
$1.03B
| $362K | ﹤0.01% |
+27,900
| New | +$383K |
|
Similar funds
OAG
JG
CHP
SC
Westfield Capital Management's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Westfield Capital Management, which disclosed 358 positions worth $14.5B. Its ten largest holdings account for 16% of the portfolio.
Its largest position is Apple: 25,321,464 shares worth $359M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, followed by Healthcare and Technology.
- Westfield Capital Management's largest Q2 2013 buy was Apple: 25,321,464 shares worth $359M.
- Westfield Capital Management's ten largest holdings make up 16% of its $14.5B portfolio in Q2 2013.
- Westfield Capital Management disclosed 358 positions in Q2 2013, its first 13F filing on record.
Based on Westfield Capital Management's 13F filing for Q2 2013, filed 9 Aug 2013.